• Epalrestat and the Polyol Pathway: A Translational Lens

  2026-09-24

  The polyol pathway connects glucose handling, endogenous fructose production, and cellular stress responses. This article considers how Epalrestat, an aldose reductase inhibitor, can help researchers interrogate that biology—while distinguishing established mechanism from the still-unproven possibility of translating polyol pathway inhibition into cancer research.

• Estradiol Benzoate: Reliable ERα Assay Workflows

  2026-09-23

  A practical guide to using Estradiol Benzoate (SKU B1941) in cell viability, proliferation, and cytotoxicity experiments without confusing receptor-binding data with cellular dose response. It covers solvent handling, assay controls, interpretation, and evidence-based product selection for estrogen receptor signaling research.

• Cell Integrity Sets Ploidy Limits in Budding Yeast

  2026-09-23

  Barker, Murray, and Bell show that budding yeast can tolerate extensive genome duplication, reaching a DNA-content range of 32–64C, but that cell-surface stress ultimately constrains further ploidy increases. Their results connect genome amplification, cell growth, surface integrity, and repression of ergosterol-biosynthesis genes, providing a mechanistic framework for studying fungal physiology and membrane stress.

• Pyridostigmine, α7nAChR, and Placental Necroptosis

  2026-09-22

  A 2026 study identifies placental necroptosis as a modifiable component of preeclampsia-like disease and links pyridostigmine’s protective effects to α7 nicotinic acetylcholine receptor signaling. Its combination of the RUPP rat model, hypoxic trophoblast assays, α-Bungarotoxin blockade, and necrostatin-1 comparison provides a pharmacological framework for testing cholinergic regulation of placental injury.

• HSP90 Controls RNA Foci in Myotonic Dystrophy

  2026-09-22

  Johnson and colleagues used an unbiased RNA-FISH small-molecule screen to identify HSP90 as a regulator of endogenous CUG-repeat RNA foci and DMPK mRNA in Myotonic Dystrophy type 1. The study connects HSP90 activity with p-STAT3 signaling in undifferentiated myoblasts while showing that differentiation reverses the transcriptional response, an important constraint for therapeutic interpretation.

• TNF-alpha Recombinant Murine Protein: Assay Logic

  2026-09-21

  TNF-alpha recombinant murine protein provides a defined receptor-initiated comparator for apoptosis and inflammation studies. This guide integrates P1002 specifications with the 2025 RNA Pol II degradation findings to improve causal interpretation of cell-death assays.

• PEP, cGAS–STING, and Healthy Aging

  2026-09-21

  The reference study identifies phosphoenolpyruvate (PEP) as an age-regulated glycolytic metabolite that temporarily protects against cGAS–STING-driven inflammation before declining later in life. Its combination of longitudinal profiling, plasma-transfer experiments, metabolic intervention, binding analysis, and an Alzheimer’s disease model links central carbon metabolism with inflammaging and suggests a framework for studying endogenous geroprotective responses.

• From Retinal Gliosis to IL-7 mRNA Translation

  2026-09-20

  A translational framework connecting glial regulation, pathological angiogenesis, and exploratory cytokine mRNA research. The article uses evidence from a 2024 ocular angiogenesis study to position EZ Cap™ Mouse IL-7 mRNA (m1Ψ, HA tag) as a defined tool for testing mechanism, localization, and translational feasibility—not as an unvalidated therapeutic claim.

• A-1210477: A Strategic MCL-1 Inhibitor Playbook

  2026-09-19

  A mechanistic and translational guide to using A-1210477 to interrogate MCL-1-dependent cancer cell survival, mitochondrial apoptosis, combination responses, and the limits of preclinical interpretation.

• Epalrestat: Linking Polyol Flux to Nrf2 Assays

  2026-09-18

  Epalrestat is an aldose reductase inhibitor with a distinctive research profile spanning polyol pathway inhibition and KEAP1/Nrf2 biology. This article presents an assay-centered framework for separating metabolic effects from neuroprotective mechanism in diabetic neuropathy research and Parkinson’s disease models.

• AZD0156: Designing Better ATM Inhibitor Assays

  2026-09-18

  AZD0156 is a selective ATM kinase inhibitor for dissecting DNA damage response and metabolic vulnerabilities. This guide translates evidence from high-grade serous ovarian cancer research into practical assay-design decisions, emphasizing combination logic, senescence readouts, and experimental interpretation.

• Ginsenoside Rg1: Reliable Assay Workflows

  2026-09-17

  Learn how Ginsenoside Rg1, SKU N1613, can support more interpretable cell viability, cytotoxicity, apoptosis, and neuroimmune experiments. This scenario-based guide connects solubility, study parameters, assay controls, and supplier-quality decisions to practical laboratory workflows.

• Nuclear PI3P Connects Vps34 to DNA Mismatch Repair

  2026-09-17

  The reference study identifies nuclear phosphatidylinositol-3-phosphate (PI3P), generated by the Beclin-1/Vps34 complex, as a functional cofactor for DNA mismatch repair. Its findings connect lipid signaling with MutSα and MutSβ assembly, DNA binding, microsatellite stability, and DNA damage responses through an autophagy-independent mechanism.

• Spirocyclic POM Analogues Target MmpL3 in TB

  2026-09-16

  This 2024 Bioorganic Chemistry study developed spirocyclic phenyl oxazole methyl derivatives and identified compound 5c as an active anti-tubercular lead against Mycobacterium tuberculosis and drug-resistant clinical isolates. Genetic resistance mapping, docking, ADME, pharmacokinetic, and THP-1 cytotoxicity data together support MmpL3 as the likely target and provide a foundation for further optimization.

• DOPE Workflows for Delivery and Fungal Assays

  2026-09-16

  1,2-Dioleoyl-sn-glycero-3-PE (DOPE) is both an endosomal-fusion helper for nucleic acid delivery and a practical phosphatidylethanolamine rescue reagent for fungal developmental assays. This guide connects formulation, conidial ferroptosis experiments, solvent handling, and troubleshooting without treating a rescue result as proof of a single molecular target.

8513 records 1/568 page Next 12345 下5页 Last page